This federal Cooperative Agreement award, funded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program, provides $400,000 to the University of Sciences, Techniques and Technologies of Bamako (Usttb) in Mali. The purpose of this award is to conduct entomological surveillance, insecticide-treated bed net (ITNs) durability monitoring, and routine monitoring of antimalarial drug efficacy and detection of resistance...
This $3,850,000 Project Grant awarded on September 18, 2023 by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program will support Maisha Healthcare, Inc., a for-profit, woman-owned small business, in scaling a digital approach to targeted malaria treatment in Uganda over a 3-year period. The funded activities are intended to promote long-term and equitable economic growth and advance U.S. foreign policy objectives...
This $1,600,540 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to accelerate malaria prevention and treatment in Malawi. The key products and services to be delivered include:
Evaluating the impacts of the RTS,S malaria vaccine and new dual-insecticide treated bed nets on the epidemiology of clinical malaria, Plasmodium falciparum infection, and...
This $2,500,000 Cooperative Agreement, awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program, aims to improve the tuberculosis (TB) epidemic response in Mozambique's high-burden northern and central provinces. The five-year award, effective July 12, 2024, will be implemented by the Center for Collaboration in Health, a non-profit non-governmental organization based in Maputo, Mozambique. The project will focus...
This Cooperative Agreement award of $6,545,200.00 from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to achieve sustainable, equitable, and resilient health systems through locally led, evidence-driven, and context-specific approaches to health system strengthening. The award, with a period of performance from December 19, 2024 to December 18, 2029, will be implemented by the non-profit organization...
This Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program provides $21,773,964 to improve the quality, accessibility, affordability, and utilization of healthcare services and enhance community involvement in three highly urbanized districts in Uganda. The award recipient, Jhpiego Corp, will implement activities to reduce maternal, newborn, and child morbidity/mortality, unmet need for...
This Cooperative Agreement, awarded by the Defense Health Agency, provides $568,275 in funding to Conserv Bioscience LIMITED, a foreign-owned for-profit organization, to develop an mRNA multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets against malaria infection. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical...
This Project Grant award, with a total funding of $7,325,000, was provided by the Millennium Challenge Corporation (MCC) under the MCC Foreign Assistance for Overseas Programs (CFDA 85.002). The funding supports global development initiatives aimed at reducing poverty through economic growth in The Gambia. The grant will likely finance activities such as policy reform, institutional capacity building, infrastructure development, and delivery of social services across sectors including...
This $18,348,780.00 Cooperative Agreement award by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to strengthen key elements of the Ugandan health system, with a focus on health care financing, human resources for health, health management information systems (HMIS), and community health systems. The award period spans from November 25, 2024 to November 23, 2029.
The prime awardee, Management Sciences for...
This federal Cooperative Agreement award for $11,975,099.00, with an initial period of performance from October 1, 2024 to September 30, 2029, is funded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas program (CFDA 98.001). The award aims to sustain the achievements of Lesotho's HIV response by preventing new infections in girls and young women and strengthening the wellbeing of highly vulnerable children and adolescents,...